Gleevec
Drug timelines are a Plus or Pro feature.
165 regulatory and trial events tracked for Gleevec, covering 2006-05-31 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) [Phase 2]